Intermittent administration of a fasting-mimicking diet in type 2 diabetes patients: a clinical cohort study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR1900002599

Enrollment

Unknown

Registered

2019-09-16

Start date

2019-10-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

B:The meal replacement product is used for 2 consecutive days every week, and the original diet structure is maintained for the remaining 5 days. At the same time, the dose of the original hypoglycemi

A:Maintain the original diet structure, you can adjust the dose of the original hypoglycemic drugs or increase the hypoglycemic drugs

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Type 2 diabetes patients between the ages of 35-70, male or female; 2. Drug-treated and diet-stable type 2 DM patients; 3. Patients with BMI >= 24kg / M2; 4. Patients agree to participate in treatment observations and can closely cooperate in observation, can adhere to the prescribed diet; 5. Patients are required to sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Severely abnormal liver and kidney function, gastrointestinal disease; patients with acute complications; or other serious comorbidities; 2. Suspected or indeed have a history of alcohol or drug abuse, or other lesions that reduce the likelihood of enrollment or complicate enrollment, according to the investigator's judgment; 3. Patients who have participated in other clinical trials in the past 3 months; 4. The observer believes that any other condition or disease patient should be excluded from this observation.

Design outcomes

Primary

Measure	Time frame
fasting blood glucose;Fasting insulin;fasting C peptide;Physical component;SMBG;HbA1c;	—

Secondary

Measure	Time frame
Liver and kidney function;	—

Countries

China

Contacts

Public ContactBo Feng

Shanghai East Hospital

fengbodfyy@tongji.edu.cn+86 13301921056

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026